Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Says Paper Published In Nature Medicine By Company Scientists To Be Retracted

This article was originally published in The Pink Sheet Daily

Executive Summary

GSK confirms dismissal of R&D China Head Jingwu Zang. GSK internal communication seen by PharmAsia News alleges “disturbing efforts” by employees to undermine an internal investigation into a paper on preclinical research; GSK suspends programs related to IL-7 receptor signaling pathway.

Advertisement

Related Content

GSK Jumps Into Growing China R&D Space

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS075815

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel